Sage Therapeutics, Inc. (SAGE) Insider Trading -- Recent Executive & Director Transactions
7 insiders reported 13 Form 4 transactions for Sage Therapeutics, Inc. (SAGE) over the past 18 months (most recent 2025-07-31). Recent activity: Benecchi Christopher (Chief Operating Officer) Sell 36,375 shares, Barrett Elizabeth A. (Director) Sell 3,000 shares, Shiferman Gregory L. (Senior Vice President, General Counsel and Secretary) Sell 7,215 shares, Shiferman Gregory L. (Senior Vice President, General Counsel and Secretary) Sell 23,735 shares, FRATES JAMES M (Director) Sell 2,845 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-31 | Benecchi Christopher | Chief Operating Officer | Sell | 36,375 | $0 |
| 2025-07-31 | Barrett Elizabeth A. | Director | Sell | 3,000 | $0 |
| 2025-07-31 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | Sell | 7,215 | $0 |
| 2025-07-31 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | Sell | 23,735 | $0 |
| 2025-07-31 | FRATES JAMES M | Director | Sell | 2,845 | $0 |
| 2025-07-31 | Benecchi Christopher | Chief Operating Officer | Sell | 28,053 | $0 |
| 2025-07-31 | Golumbeski George | Director | Sell | 8,000 | $0 |
| 2025-07-31 | Greene Barry E | President and CEO | Sell | 46,940 | $0 |
| 2025-07-31 | Greene Barry E | President and CEO | Sell | 53,229 | $0 |
| 2025-07-31 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | Sell | 24,999 | $0 |
| 2025-07-31 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | Sell | 7,962 | $0 |
| 2025-06-26 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | Sell | 79 | $728 |
| 2025-06-26 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | Sell | 113 | $1,042 |
Source: SEC Form 4 filings · as of 2025-07-31